Clinuvel Pharmaceuticals Limited (CUV) - Research

$22.4000.48 (2.19%)
Prices as at 16:40, 26 Apr 2019

CUV Current Share Price+

Current Price $22.400
Open $22.310
High $22.590
Low $22.000
Last Close $21.920
Volume 118670
Price Movement $0.48 ( 2.19% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

CUV General Information

Clinuvel Pharmaceuticals Limited
CUV
http://www.clinuvel.com
Biotechnology
1,096
49

CUV Company Overview

Business Description

Clinuvel Pharmaceuticals Limited (CUV) is a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. CUV's lead compound is SCENESSE (afamelanotide), a drug targeting erythropoietic protoporphyria (EPP).

CUV Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A 13.22 26.70 86.70% 32.50 2.00 0.20% 0.0%
2017 A 7.11 14.30 0.00% 46.50 0.00 0.00% 0.0%
2016 A -3.15 -7.00 0.00% 0.00 0.00 0.00% 0.0%

CUV Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
CSL (CSL) $86,257M 0.3775 0.1257 0.1290 36.2679 32.2170 28.5348 1.62% 1.42% 1.63%
Clinuvel Pharmaceuticals (CUV) $1,089M 0.8671 0.0000 0.0000 83.3333 0.0000 0.0000 0.09% 0.00% 0.00%
Mesoblast (MSB) $780M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $249M -0.2744 0.0000 0.0000 11.6318 0.0000 0.0000 5.69% 0.00% 0.00%
Polynovo (PNV) $612M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

CUV Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 1.04 82.10 26.60 0.00
Market 0.71 14.90 1.20 1.08
Sector 1.02 24.40 3.31 2.83

CUV Directors

Name Position Start Date
Dr Philippe J Wolgen Chief Executive Officer, Managing Director 1 Oct 2005
Ms Brenda Mary Shanahan Non-Executive Director 6 Feb 2007
Mr Willem A Blijdorp Non-Executive Director 21 Jan 2015
Dr Karen Agersborg Non-Executive Director 29 Jan 2018
Mr Stanley R McLiesh Non-Executive Director, Non-Executive Chairman 12 Sep 2002

CUV Management

Name Position
Darren Keamy Chief Finance Officer,Company Secretary
Dennis Wright Chief Scientific Officer

CUV Substantial Shareholders

Holding Name
3,666,998 (7.66%) Dr Philippe Jacques Wolgen

CUV Calendar of Events

Date Event
25 February 2020 Report (Interim)
18 October 2019 Report (Annual)
28 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.